Fibrogenesis in Crohn's Disease
The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Over one-third of patients with Crohn's disease (CD) will develop an intestinal stricture and the great majority of these will require at least one surgical procedure. While the pathogenesis of inflammation in CD has been extensively investigated, knowledge of stricture pathogenesis remains limited. The aim of this review is to discuss the current understanding of fibrogenesis in CD and to outline potential directions in research and therapeutics. METHODS: The electronic literature (January 1966 to May 2006) on CD-associated fibrosis was reviewed. Further references were obtained by cross-referencing from key articles. RESULTS: CD-associated fibrosis results from chronic transmural inflammation and a complex interplay among intestinal mesenchymal cells, cytokines, and local inflammatory cells. The fibroblast is the key cell type mediating stricture formation. The cytoarchitecure of the bowel wall is altered with disruption of the muscularis mucosa, thickening of the muscularis propria, and deposition of collagen throughout. The cytokine TGF-beta appears critical in this process, acting to increase growth factor and extracellular matrix (ECM) production and dysregulate ECM turnover. Potential therapeutic interventions are likely to concentrate on modulating down-stream targets of TGF-beta. CONCLUSIONS: Greater understanding of the biology of fibrostenosis is likely to yield significant advances in our ability to care for patients with stricturing CD. Potential dividends of this approach include identification of novel therapeutic targets and biomarkers useful for prognostication and therapeutic monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 1×
“CARD 15 variant on chromosome arm 16q (22, 23).”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Loftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,117
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
Long-Term Evolution of Disease Behavior of Crohn's Disease
Cosnes, J., Cattan, S., Blain, A., Beaugerie, L., Carbonnel, F., Parc, R., & Gendre, J.-P. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200207000-00002 · Cited by 1,346
(2011) · Hepatogastroenterology · doi:10.5754/hge11069 · Cited by 1,140
Gasche, C., Scholmerich, J., Brynskov, J., DʼHaens, G., Hanauer, S. B., Irvine, J. E., Jewell, D. P., Rachmilewitz, D., Sachar, D. B., Sandborn, W. J., et al. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200002000-00002 · Cited by 1,134
Louis, E., Collard, A., Oger, A. F., Degroote, E., El Yafi, F. A. N., & Belaiche, J. (2001) · Gut · doi:10.1136/gut.49.6.777 · Cited by 1,005
Cited by
Immunopathogenesis of IBD: current state of the art
de Souza, H. S. P., & Fiocchi, C. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.186 · Cited by 1,551
Roda, G., Chien Ng, S., Kotze, P. G., Argollo, M., Panaccione, R., Spinelli, A., Kaser, A., Peyrin-Biroulet, L., & Danese, S. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0156-2 · Cited by 1,023
Kugathasan, S., Denson, L. A., Walters, T. D., Kim, M.-O., Marigorta, U. M., Schirmer, M., Mondal, K., Liu, C., Griffiths, A., Noe, J. D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30317-3 · Cited by 633
Crohn's disease complicated by strictures: a systematic review
Rieder, F., Zimmermann, E. M., Remzi, F. H., & Sandborn, W. J. (2013) · Gut · doi:10.1136/gutjnl-2012-304353 · Cited by 513
Prud'homme, G. J. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700669 · Cited by 419
Inflammation-Induced Endothelial-to-Mesenchymal Transition
Rieder, F., Kessler, S. P., West, G. A., Bhilocha, S., de la Motte, C., Sadler, T. M., Gopalan, B., Stylianou, E., & Fiocchi, C. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.07.042 · Cited by 322
Ihara, S., Hirata, Y., & Koike, K. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1350-1 · Cited by 302
Inflammatory Bowel Disease: Mechanisms, Redox Considerations, and Therapeutic Targets
Biasi, F., Leonarduzzi, G., Oteiza, P. I., & Poli, G. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4530 · Cited by 300
IBD immunopathogenesis: A comprehensive review of inflammatory molecules
Park, J. H., Peyrin-Biroulet, L., Eisenhut, M., & Shin, J. I. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.02.013 · Cited by 276
Cellular and molecular mechanisms of intestinal fibrosis
Speca, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3635 · Cited by 272
Wright, K. L., Duncan, M., & Sharkey, K. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707486 · Cited by 264
Rieder, F., Latella, G., Magro, F., Yuksel, E. S., Higgins, P. D. R., Di Sabatino, A., de Bruyn, J. R., Rimola, J., Brito, J., Bettenworth, D., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw055 · Cited by 261
Rieder, F., Kessler, S., Sans, M., & Fiocchi, C. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00059.2012 · Cited by 135
“Often surgery is still the only practical solution for patients with complications secondary to intestinal fibrosis, and postsurgical recurrence is frequent (10, 114).”
BackgroundTaming the Elephant: Salmonella Biology, Pathogenesis, and Prevention
Andrews-Polymenis, H. L., Bäumler, A. J., McCormick, B. A., & Fang, F. C. (2010) · Infection and Immunity · doi:10.1128/iai.00096-10 · Cited by 114
“Although more than one-third of patients with CD develop a distinct fibrostenosing phenotype that results in recurrent intestinal stricture formation, good models that mimic the pathology of intestinal fibrosis have been lacking (26).”
BackgroundProphylactic systemic P2X7 receptor blockade prevents experimental colitis
Marques, C. C., Castelo-Branco, M. T., Pacheco, R. G., Buongusto, F., do Rosário, A., Schanaider, A., Coutinho-Silva, R., & de Souza, H. S. P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.012 · Cited by 78
Identification and Characterisation of an Iron-Responsive Candidate Probiotic
Bailey, J. R., Probert, C. S. J., & Cogan, T. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026507 · Cited by 25
“thermophilus NCIMB 41856 to reduce the production of TNFa, the principle pro-inflammatory cytokine present in this condition, is highly important and warrants further investigation; inflammation-induced fibrosis leading to stricture formation in Crohn’s disease represents a serious complication with important clinical…”
Background
Metadata
- Authors
- Burke, J. P., Mulsow, J. J., O'Keane, C., Docherty, N. G., Watson, R. W. G., & O'Connell, P. R.
- Venue
- The American Journal of Gastroenterology
- Published
- 2007-02
- Volume
- 102
- Issue
- 2
- Pages
- 439-448
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W1997413662
- Cited by
- 279
- References
- 100
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.